Spark Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-267,000
Closed -$704K 691
2017
Q4
$704K Buy
+267,000
New +$935K 0.04% 410
2017
Q3
Sell
-379,800
Closed -$1.35M 780
2017
Q2
$1.35M Buy
+379,800
New +$1.53M 0.08% 328
2017
Q1
Sell
-89,300
Closed -$339K 870
2016
Q4
$339K Buy
+89,300
New +$649K 0.03% 551
2015
Q4
Sell
-94,200
Closed -$343K 823
2015
Q3
$343K Sell
94,200
-65,200
-41% -$319K 0.04% 438
2015
Q2
$916K Sell
159,400
-77,300
-33% -$447K 0.13% 235
2015
Q1
$1.38M Sell
236,700
-33,200
-12% -$229K 0.19% 175
2014
Q4
$2.12M Sell
269,900
-24,800
-8% -$159K 0.36% 80
2014
Q3
$1.44M Sell
294,700
-82,900
-22% -$433K 0.22% 150
2014
Q2
$2.32M Sell
377,600
-151,500
-29% -$758K 0.34% 88
2014
Q1
$2.83M Buy
529,100
+372,600
+238% +$2.36M 0.44% 49
2013
Q4
$818K Sell
156,500
-18,000
-10% -$82.6K 0.14% 235
2013
Q3
$961K Buy
174,500
+75,200
+76% +$261K 0.22% 146
2013
Q2
$250K Buy
+99,300
New +$247K 0.07% 319

Other funds holding PACB

Spark Investment Management's PACB Position: Q1 2018 in Review

Spark Investment Management sold out of Pacific Biosciences (PACB) in Q1 2018, closing a stake of 267,000 shares — an estimated $704K sold.

Spark Investment Management first reported a position in PACB in Q2 2013 and held it in 13 quarters. The position peaked at $2.83M in Q1 2014. 101 funds tracked by Wall St. Rank hold PACB as of Q1 2018.

  • Spark Investment Management reported no remaining Pacific Biosciences position as of Q1 2018 after selling out during the quarter.
  • Spark Investment Management sold 267,000 Pacific Biosciences shares in Q1 2018, an estimated $704K.
  • Spark Investment Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 13 quarters.
  • Spark Investment Management's Pacific Biosciences position peaked at $2.83M in Q1 2014.
  • 101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2018.

Based on Spark Investment Management's 13F filing for Q1 2018, filed 10 May 2018.